Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
2019
Autori
Gomes, Clarissa Pedrosa da CÁgg, Bence
Andova, Andrejaana
Arslan, Serdal
Baker, Andrew
Barteková, Monika
Beis, Dimitris
Betsou, Fay
Wettinger, Stephanie Bezzina
Bugarski, Branko
Condorelli, Gianluigi
da Silva, Gustavo Jose Justo
Danilin, Sabrina
de Gonzalo-Calvo, David
Buil, Alfonso
Carmo-Fonseca, Maria
Enguita, Francisco J
Felekkis, Kyriacos
Ferdinandy, Peter
Gyöngyösi, Mariann
Hackl, Matthias
Karaduzović-Hadžiabdić, Kanita
Hellemans, Jan
Heymans, Stephane
Hlavackova, Markéta
Hoydal, Morten Andre
Janković, Aleksandra
Jusić, Amela
Kardassis, Dimitris
Kerkelä, Risto
Kuster, Gabriela M
Lakkisto, Päivi
Leszek, Przemyslaw
Lustrek, Mitja
Maegdefessel, Lars
Martelli, Fabio
Novella, Susana
O'Brien, Timothy
Papaneophytou, Christos
Pedrazzini, Thierry
Pinet, Florence
Popescu, Octavian
Potočnjak, Ines
Robinson, Emma
Sasson, Shlomo
Scholz, Markus
Simionescu, Maya
Stoll, Monika
Varga, Zoltan V
Vinciguerra, Manlio
Xuereb, Angela
Yilmaz, Mehmet Birhan
Emanueli, Costanza
Devaux, Yvan
Članak u časopisu (Objavljena verzija)
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the cl...inic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).
Izvor:
Non-Coding RNA, 2019, 5, 2, 31-Izdavač:
- MDPI, Basel
Finansiranje / projekti:
- COST (European Cooperation in Science and Technology) Action EU-CardioRNA [CA17129]
DOI: 10.3390/ncrna5020031
ISSN: 2311-553X
PubMed: 30934986
WoS: 000474931400001
Scopus: 2-s2.0-85069910260
Institucija/grupa
Tehnološko-metalurški fakultetTY - JOUR AU - Gomes, Clarissa Pedrosa da C AU - Ágg, Bence AU - Andova, Andrejaana AU - Arslan, Serdal AU - Baker, Andrew AU - Barteková, Monika AU - Beis, Dimitris AU - Betsou, Fay AU - Wettinger, Stephanie Bezzina AU - Bugarski, Branko AU - Condorelli, Gianluigi AU - da Silva, Gustavo Jose Justo AU - Danilin, Sabrina AU - de Gonzalo-Calvo, David AU - Buil, Alfonso AU - Carmo-Fonseca, Maria AU - Enguita, Francisco J AU - Felekkis, Kyriacos AU - Ferdinandy, Peter AU - Gyöngyösi, Mariann AU - Hackl, Matthias AU - Karaduzović-Hadžiabdić, Kanita AU - Hellemans, Jan AU - Heymans, Stephane AU - Hlavackova, Markéta AU - Hoydal, Morten Andre AU - Janković, Aleksandra AU - Jusić, Amela AU - Kardassis, Dimitris AU - Kerkelä, Risto AU - Kuster, Gabriela M AU - Lakkisto, Päivi AU - Leszek, Przemyslaw AU - Lustrek, Mitja AU - Maegdefessel, Lars AU - Martelli, Fabio AU - Novella, Susana AU - O'Brien, Timothy AU - Papaneophytou, Christos AU - Pedrazzini, Thierry AU - Pinet, Florence AU - Popescu, Octavian AU - Potočnjak, Ines AU - Robinson, Emma AU - Sasson, Shlomo AU - Scholz, Markus AU - Simionescu, Maya AU - Stoll, Monika AU - Varga, Zoltan V AU - Vinciguerra, Manlio AU - Xuereb, Angela AU - Yilmaz, Mehmet Birhan AU - Emanueli, Costanza AU - Devaux, Yvan PY - 2019 UR - http://TechnoRep.tmf.bg.ac.rs/handle/123456789/4094 AB - Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu). PB - MDPI, Basel T2 - Non-Coding RNA T1 - Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129 IS - 2 SP - 31 VL - 5 DO - 10.3390/ncrna5020031 ER -
@article{ author = "Gomes, Clarissa Pedrosa da C and Ágg, Bence and Andova, Andrejaana and Arslan, Serdal and Baker, Andrew and Barteková, Monika and Beis, Dimitris and Betsou, Fay and Wettinger, Stephanie Bezzina and Bugarski, Branko and Condorelli, Gianluigi and da Silva, Gustavo Jose Justo and Danilin, Sabrina and de Gonzalo-Calvo, David and Buil, Alfonso and Carmo-Fonseca, Maria and Enguita, Francisco J and Felekkis, Kyriacos and Ferdinandy, Peter and Gyöngyösi, Mariann and Hackl, Matthias and Karaduzović-Hadžiabdić, Kanita and Hellemans, Jan and Heymans, Stephane and Hlavackova, Markéta and Hoydal, Morten Andre and Janković, Aleksandra and Jusić, Amela and Kardassis, Dimitris and Kerkelä, Risto and Kuster, Gabriela M and Lakkisto, Päivi and Leszek, Przemyslaw and Lustrek, Mitja and Maegdefessel, Lars and Martelli, Fabio and Novella, Susana and O'Brien, Timothy and Papaneophytou, Christos and Pedrazzini, Thierry and Pinet, Florence and Popescu, Octavian and Potočnjak, Ines and Robinson, Emma and Sasson, Shlomo and Scholz, Markus and Simionescu, Maya and Stoll, Monika and Varga, Zoltan V and Vinciguerra, Manlio and Xuereb, Angela and Yilmaz, Mehmet Birhan and Emanueli, Costanza and Devaux, Yvan", year = "2019", abstract = "Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu).", publisher = "MDPI, Basel", journal = "Non-Coding RNA", title = "Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129", number = "2", pages = "31", volume = "5", doi = "10.3390/ncrna5020031" }
Gomes, C. P. d. C., Ágg, B., Andova, A., Arslan, S., Baker, A., Barteková, M., Beis, D., Betsou, F., Wettinger, S. B., Bugarski, B., Condorelli, G., da Silva, G. J. J., Danilin, S., de Gonzalo-Calvo, D., Buil, A., Carmo-Fonseca, M., Enguita, F. J., Felekkis, K., Ferdinandy, P., Gyöngyösi, M., Hackl, M., Karaduzović-Hadžiabdić, K., Hellemans, J., Heymans, S., Hlavackova, M., Hoydal, M. A., Janković, A., Jusić, A., Kardassis, D., Kerkelä, R., Kuster, G. M., Lakkisto, P., Leszek, P., Lustrek, M., Maegdefessel, L., Martelli, F., Novella, S., O'Brien, T., Papaneophytou, C., Pedrazzini, T., Pinet, F., Popescu, O., Potočnjak, I., Robinson, E., Sasson, S., Scholz, M., Simionescu, M., Stoll, M., Varga, Z. V., Vinciguerra, M., Xuereb, A., Yilmaz, M. B., Emanueli, C.,& Devaux, Y.. (2019). Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. in Non-Coding RNA MDPI, Basel., 5(2), 31. https://doi.org/10.3390/ncrna5020031
Gomes CPDC, Ágg B, Andova A, Arslan S, Baker A, Barteková M, Beis D, Betsou F, Wettinger SB, Bugarski B, Condorelli G, da Silva GJJ, Danilin S, de Gonzalo-Calvo D, Buil A, Carmo-Fonseca M, Enguita FJ, Felekkis K, Ferdinandy P, Gyöngyösi M, Hackl M, Karaduzović-Hadžiabdić K, Hellemans J, Heymans S, Hlavackova M, Hoydal MA, Janković A, Jusić A, Kardassis D, Kerkelä R, Kuster GM, Lakkisto P, Leszek P, Lustrek M, Maegdefessel L, Martelli F, Novella S, O'Brien T, Papaneophytou C, Pedrazzini T, Pinet F, Popescu O, Potočnjak I, Robinson E, Sasson S, Scholz M, Simionescu M, Stoll M, Varga ZV, Vinciguerra M, Xuereb A, Yilmaz MB, Emanueli C, Devaux Y. Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. in Non-Coding RNA. 2019;5(2):31. doi:10.3390/ncrna5020031 .
Gomes, Clarissa Pedrosa da C, Ágg, Bence, Andova, Andrejaana, Arslan, Serdal, Baker, Andrew, Barteková, Monika, Beis, Dimitris, Betsou, Fay, Wettinger, Stephanie Bezzina, Bugarski, Branko, Condorelli, Gianluigi, da Silva, Gustavo Jose Justo, Danilin, Sabrina, de Gonzalo-Calvo, David, Buil, Alfonso, Carmo-Fonseca, Maria, Enguita, Francisco J, Felekkis, Kyriacos, Ferdinandy, Peter, Gyöngyösi, Mariann, Hackl, Matthias, Karaduzović-Hadžiabdić, Kanita, Hellemans, Jan, Heymans, Stephane, Hlavackova, Markéta, Hoydal, Morten Andre, Janković, Aleksandra, Jusić, Amela, Kardassis, Dimitris, Kerkelä, Risto, Kuster, Gabriela M, Lakkisto, Päivi, Leszek, Przemyslaw, Lustrek, Mitja, Maegdefessel, Lars, Martelli, Fabio, Novella, Susana, O'Brien, Timothy, Papaneophytou, Christos, Pedrazzini, Thierry, Pinet, Florence, Popescu, Octavian, Potočnjak, Ines, Robinson, Emma, Sasson, Shlomo, Scholz, Markus, Simionescu, Maya, Stoll, Monika, Varga, Zoltan V, Vinciguerra, Manlio, Xuereb, Angela, Yilmaz, Mehmet Birhan, Emanueli, Costanza, Devaux, Yvan, "Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129" in Non-Coding RNA, 5, no. 2 (2019):31, https://doi.org/10.3390/ncrna5020031 . .